Cargando…
Lipoprotein(a) Induces Vesicular Cardiovascular Calcification Revealed With Single-Extracellular Vesicle Analysis
Lipoprotein(a) (Lp[a]) blood levels >50 mg/dL is a major cardiovascular disease risk factor in humans. Lp(a) associates with increased cardiovascular calcification, a critical pathology with no clinically available drug therapies. The mechanisms through which Lp(a) increases cardiovascular calcif...
Autores principales: | Rogers, Maximillian A., Atkins, Samantha K., Zheng, Kang H., Singh, Sasha A., Chelvanambi, Sarvesh, Pham, Tan H., Kuraoka, Shiori, Stroes, Erik S. G., Aikawa, Masanori, Aikawa, Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831739/ https://www.ncbi.nlm.nih.gov/pubmed/35155626 http://dx.doi.org/10.3389/fcvm.2022.778919 |
Ejemplares similares
-
Induced pluripotent stem cell-derived smooth muscle cells to study cardiovascular calcification
por: Atkins, Samantha K., et al.
Publicado: (2022) -
Computational Screening Strategy for Drug Repurposing Identified Niclosamide as Inhibitor of Vascular Calcification
por: Tanaka, Takeshi, et al.
Publicado: (2022) -
Editorial: Extracellular vesicles in cardiovascular inflammation and calcification
por: Krohn, Jona B., et al.
Publicado: (2022) -
Standardization of Human Calcific Aortic Valve Disease in vitro Modeling Reveals Passage-Dependent Calcification
por: Goto, Shinji, et al.
Publicado: (2019) -
Extracellular Vesicles As Mediators of Cardiovascular Calcification
por: Bakhshian Nik, Amirala, et al.
Publicado: (2017)